HOME >> BIOLOGY >> NEWS
Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds

CHICAGO Obtaining complete and accurate medication histories of patients and instituting a medication reconciliation program are vital to reducing medication errors, a new study conducted at Northwestern Memorial Hospital has shown. The study demonstrated that when hospital pharmacists perform medication reconciliation, taking steps to ensure patients receive the correct medication and accurate dosage, the number of medication errors dropped and with them the potential for patient injury.

"A medication error, once in a patient's medical record, can carry-over from admission through discharge unless medication reconciliation is performed," says Kristine Gleason, who is on the hospital's Patient Safety Team and is the lead author of the study, Reconciliation of Discrepancies in Medication Histories and Admission Orders of Newly Hospitalized Patients. "Doctors, nurses, pharmacists and patients often just assume medical histories are accurate, and that's not always the case."

The study findings, published this week in the American Journal of Health-System Pharmacy, are particularly significant in light of the recent announcement by the Joint Commission on Accreditation of Healthcare Organizations that medication reconciliation for all hospital patients is one of its 2005 National Patient Safety Goals. That means medication reconciliation programs are a requirement for accreditation.

Northwestern Memorial is working toward that goal, implementing a computerized prescriber order entry (CPOE) system as part of its patient safety initiative. A previous study at Northwestern Memorial found that a combination of pharmacist involvement and a CPOE system with significant clinical decision support will likely provide the best approach to improve medication safety among patients.

Data collected by Northwestern Memorial researchers for the new study showed that in the absence of a pharmacist intervention, 22 percent of medication discrepan
'"/>

Contact: Andrew Buchanan
anbuchan@nmh.org
312-926-6503
Northwestern Memorial Hospital
16-Aug-2004


Page: 1 2 3

Related biology news :

1. Possible Dangers Of Taking Over-The-Counter Medications For Hepatitis C Patients
2. Common Anti-Viral Medication Prevents Severe Eye Herpes
3. New Medication Means New Choices For Families Dealing With Alzheimers Disease
4. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
5. Call for greater involvement of developing world scientists in fight against AIDS
6. Yale researchers shed light on B cells involvement in autoimmune diseases like lupus
7. Education, monitoring vital for sport-fish eaters
8. Life goes on without vital DNA
9. Rb2 expression could play vital role in ovarian cancer Temple University researchers find
10. Vascular access vital to pump up tissue engineering
11. Study links amyloid plaques in Alzheimers brains to genes vital to normal memory

Post Your Comments:
(Date:10/22/2014)... Aware, Inc. (NASDAQ: AWRE ), a ... results for its third quarter ended September 30, 2014. ... million, an increase of 40% compared to $4.3 million in ... quarter of 2014 was $4.1 million compared to $1.0 million ... the current three month period was primarily due to: i) ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... is available in German . ... very few drugs. When treating overdoses, doctors are often limited ... difficult if there is a combination of drugs involved. So ... accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux from ... find an answer to this question. "The task was to ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/20/2014)... Inc. (NASDAQ: GNVC ) today announced the retirement ... of directors effective on October 24, 2014.   Dr. Horovitz joined ... chairman from June 2006 to November 2013.  During his tenure, ... Audit Committees of the board.  "We deeply ... to GenVec, and its stockholders," said Wayne T. Hockmeyer ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy ... of donor stem cells for dogs with osteoarthritis. Dr. ... has performed clinical stem cell therapy for 7 years. ... if a single injection of donor stem cells into ... pain and inflammation in the treated joints. , ...
(Date:10/19/2014)... 19, 2014 The Asia-Pacific Bromine ... in Asia-Pacific with analysis and forecast of revenue. ... Pacific Bromine Market report, to get an idea ... a glimpse of the segmentation in the Asia-Pacific ... and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , ...
(Date:10/19/2014)... 19, 2014 The Asian Orthopedic braces and ... Asia with analysis and forecast of revenue. The Orthopedic braces ... to around $416.5 million by 2018, at a developing CAGR ... TOC of the Asian Orthopedic braces and support systems market, ... also provides a glimpse of the segmentation of orthopedic braces ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4
Cached News: